Institutional investors hold a majority ownership of ABBV through the 70.73% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2013, these large investors purchased a net $25.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 16.3 Million shares of AbbVie Inc
NORGES BANK INVESTMENT MANAGEMEN... Bought 11.7 Million shares of AbbVie Inc
FIL INVESTMENTS INTERNATIONAL Bought 4.3 Million shares of AbbVie Inc